Kiniksa Pharmaceuticals International Plc (KNSA)
47.71
+0.54
(+1.14%)
USD |
NASDAQ |
Feb 20, 16:00
48.29
+0.58
(+1.22%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.2303 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| NovoCure Ltd. | -0.333 |
| LivaNova Plc | 0.4856 |
| ADMA Biologics, Inc. | 0.1489 |
| Alterola Biotech, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.44M |
| Revenue (Quarterly) | 180.86M |
| Total Expenses (Quarterly) | 162.42M |
| Enterprise Value | 3.233B |
| Gross Profit Margin (Quarterly) | 53.78% |
| Profit Margin (Quarterly) | 10.19% |
| Earnings Yield | 0.94% |
| Operating Earnings Yield | 1.04% |
| Normalized Earnings Yield | 0.9398 |